CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 51 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $158,987 | +160.6% | 7,828 | +183.2% | 0.00% | – |
Q2 2021 | $61,000 | -30.7% | 2,764 | -62.8% | 0.00% | -100.0% |
Q1 2020 | $88,000 | -70.0% | 7,437 | -64.1% | 0.00% | -50.0% |
Q3 2019 | $293,000 | -40.4% | 20,701 | -50.6% | 0.00% | -60.0% |
Q1 2019 | $492,000 | +53.8% | 41,937 | +115.8% | 0.01% | +66.7% |
Q1 2018 | $320,000 | +290.2% | 19,429 | +180.5% | 0.00% | +200.0% |
Q2 2017 | $82,000 | +95.2% | 6,926 | -10.0% | 0.00% | – |
Q2 2016 | $42,000 | -27.6% | 7,699 | -37.4% | 0.00% | -100.0% |
Q1 2016 | $58,000 | +87.1% | 12,304 | +95.2% | 0.00% | – |
Q4 2015 | $31,000 | +3000.0% | 6,304 | +1776.2% | 0.00% | – |
Q3 2015 | $1,000 | -97.5% | 336 | -94.9% | 0.00% | -100.0% |
Q2 2015 | $40,000 | +73.9% | 6,636 | +61.9% | 0.00% | – |
Q1 2015 | $23,000 | +1050.0% | 4,100 | +485.7% | 0.00% | – |
Q4 2014 | $2,000 | -88.9% | 700 | -89.4% | 0.00% | – |
Q3 2014 | $18,000 | -72.3% | 6,593 | -71.5% | 0.00% | -100.0% |
Q2 2014 | $65,000 | -66.7% | 23,109 | -48.2% | 0.00% | -66.7% |
Q1 2014 | $195,000 | – | 44,638 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INGALLS & SNYDER LLC | 8,360,485 | $186,021 | 8.91% |
Novo Holdings A/S | 3,377,768 | $75,155,338 | 5.81% |
Parallel Advisors, LLC | 3,726,565 | $82,916,071 | 2.67% |
TANAKA CAPITAL MANAGEMENT INC | 35,539 | $791 | 2.14% |
S&T BANK/PA | 347,260 | $7,727 | 1.39% |
FAS Wealth Partners, Inc. | 310,771 | $6,914,655 | 0.88% |
Birchview Capital, LP | 50,000 | $1,112,500 | 0.83% |
Granite Investment Partners, LLC | 792,519 | $17,633,548 | 0.70% |
Bridge City Capital, LLC | 60,632 | $1,349,062 | 0.64% |
AJ WEALTH STRATEGIES, LLC | 509,934 | $11,346,032 | 0.55% |